Skip to content
Merito
← Back to results
EB-2 NIWFinance and economicsIndividualDecided June 2024Dismissed

Outcome: Dismissed

JUN102024_05B5203

Merit and national importanceNot metWell positionedNot reached / not discussedBalance favors a waiverNot reached / not discussed

Our summary

Pharmaceutical and healthcare consultant sought EB-2 with national interest waiver to provide professional advice through independent consultancy. AAO dismissed appeal, finding proposed endeavor lacked national importance; insufficient evidence of broader field implications or substantial positive economic effects beyond individual clients.

Official PDF

Official PDF ↗

Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.

No criterion in the table was found met in this decision.

What was missing

  • Merit and national importance · Proposed pharmaceutical and healthcare consultancy lacks national importance; benefits limited to selected clients without broader implications.

Criteria

CriterionReadingWhy
Merit and national importanceNot metProposed pharmaceutical and healthcare consultancy lacks national importance; benefits limited to selected clients without broader implications.
Well positionedNot reached / not discussedFirst prong failed; second prong not analyzed as dispositive issue reached.
Balance favors a waiverNot reached / not discussedFirst prong failed; third prong not analyzed as dispositive issue reached.

A published decision describes one case. It is not legal advice and not a prediction for yours.

Similar decisions

Decisions whose text is closest to this one.